Search Results for "block"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for block. Results 321 to 330 of 331 total matches.
Drugs for Inflammatory Bowel Disease
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023 (Issue 1680)
.21,22
IL-12 AND IL-23 ANTAGONIST — Ustekinumab
(Stelara) is an anti-p40 antibody that blocks ...
Ulcerative colitis (UC) and Crohn's disease (CD),
referred to collectively as inflammatory bowel disease
(IBD), are chronic immune-mediated inflammatory
conditions. Guidelines for treatment of UC and CD
have been updated in recent years
Med Lett Drugs Ther. 2023 Jul 10;65(1680):105-12 doi:10.58347/tml.2023.1680a | Show Introduction Hide Introduction
Comparison Table: Some Oral Antiseizure Medications (online only)
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
,
tremor
Rarely: asymptomatic
first-degree AV block (due
to PR interval prolongation),
atrial ...
View the Comparison Table: Some Oral Antiseizure Medications
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e133-40 doi:10.58347/tml.2024.1708b | Show Introduction Hide Introduction
Drugs for Chronic Heart Failure
The Medical Letter on Drugs and Therapeutics • May 26, 2025 (Issue 1729)
is reached (see
Table 2).
Adverse Effects – ARBs, like ACE inhibitors, block the
effects of angiotensin II ...
Pharmacologic management of chronic heart failure
(HF) is primarily determined by the patient's left
ventricular ejection fraction (LVEF) and severity of
symptoms. Patients with chronic HF who have an
LVEF ≤40% are considered to have heart failure with
reduced ejection fraction (HFrEF) and those with an
LVEF ≥50% are considered to have heart failure with
preserved ejection fraction (HFpEF). Patients with an
LVEF of 41-49% have heart failure with mildly reduced
or mid-range ejection fraction.
Med Lett Drugs Ther. 2025 May 26;67(1729):81-8 doi:10.58347/tml.2025.1729a | Show Introduction Hide Introduction
Drugs for Tuberculosis
Treatment Guidelines from The Medical Letter • Apr 01, 2012 (Issue 116)
, and can block
the hypouricemic action of allopurinol. It is the most
common cause of drug rash among ...
Tuberculosis (TB) is still a common cause of death
worldwide, and the prevalence of drug-resistant TB
poses challenges to its treatment and control.
Guidelines with detailed management recommendations
are available from the American Thoracic
Society, Centers for Disease Control and Prevention
(CDC) and Infectious Diseases Society of America
(IDSA).
Antifungal Drugs
Treatment Guidelines from The Medical Letter • Aug 01, 2012 (Issue 120)
. It inhibits squalene epoxidase
which blocks ergosterol synthesis and results in
fungal cell death.
The most ...
The drugs of choice for treatment of fungal infections
are listed in the table that begins on page 62. Some of
the indications and dosages recommended here have
not been approved by the FDA. More detailed guidelines
for some of these infections are available online
from the Infectious Diseases Society of America
(www.idsociety.org).
Drugs for Common Eye Disorders
The Medical Letter on Drugs and Therapeutics • Dec 02, 2019 (Issue 1586)
, dizziness, bradycardia, respiratory
depression, and masking of hypoglycemia. These
drugs can block ...
This issue includes reviews of drugs for glaucoma,
age-related macular degeneration (AMD), bacterial
conjunctivitis, and dry eye disease. Allergic conjunctivitis
is reviewed in a separate issue.
Drugs for ADHD
The Medical Letter on Drugs and Therapeutics • Jan 27, 2020 (Issue 1590)
effects such as
bradycardia and AV block.
ATOMOXETINE — The selective norepinephrine
reuptake inhibitor ...
Attention-deficit/hyperactivity disorder (ADHD) is a
chronic neurodevelopmental disorder that has been
diagnosed in up to 10% of school-age children in the
US and frequently persists into adulthood. A study in
a large Danish cohort found that ADHD was associated
with higher mortality rates in children, adolescents,
and adults, mainly due to accidents. Pharmacologic
treatment of ADHD in children has been reported to
decrease the risk of substance abuse in adolescents,
and use of ADHD medications in adults has been
associated with a reduced risk of serious traffic
accidents and...
Drugs for Anxiety Disorders
The Medical Letter on Drugs and Therapeutics • Aug 07, 2023 (Issue 1682)
.
OTHER AGENTS — The sedating antidepressant
mirtazapine (Remeron, and others) blocks
presynaptic alpha2 ...
Anxiety disorders (generalized anxiety disorder,
panic disorder, social anxiety disorder, and various
phobias) are the most common form of psychiatric
illness. They can be treated effectively with cognitive
behavioral therapy (CBT) and/or pharmacotherapy.
Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-8 doi:10.58347/tml.2023.1682a | Show Introduction Hide Introduction
Drugs for Depression
The Medical Letter on Drugs and Therapeutics • Dec 11, 2023 (Issue 1691)
appetite, and hypertension. Dose-related seizures can occur.
MIRTAZAPINE — Mirtazapine blocks presynaptic ...
A selective serotonin reuptake inhibitor (SSRI) is
generally used for initial treatment of major depressive
disorder (MDD). A serotonin-norepinephrine reuptake
inhibitor (SNRI), bupropion (Wellbutrin SR, and
others), and mirtazapine (Remeron, and others) are
reasonable alternatives. Improvement in symptoms
can occur within the first two weeks of treatment
with these drugs, but a substantial benefit may not be
achieved for 4-8 weeks.
Med Lett Drugs Ther. 2023 Dec 11;65(1691):193-200 doi:10.58347/tml.2023.1691a | Show Introduction Hide Introduction
Drugs for HIV Infection
Treatment Guidelines from The Medical Letter • Feb 01, 2014 (Issue 138)
that results in viral
DNA insertion into the host genome. INSTIs block the
enzyme’s activity, preventing ...
Antiretroviral therapy is recommended for all HIV-infected
patients, both to reduce the risk of disease
progression and to prevent transmission of the virus to
others. Various guidelines for treatment of HIV infection
are available.